UroToday.com - In the August 20, 2008 issue of the Journal of Clinical Oncology, Dr. John C. Cheville and associates from the Mayo Clinic proposed a predictive model, that includes genetic markers, for men at high risk of prostate cancer progression after radical prostatectomy (RP). From 1990-2004, patients treated with RP at the Mayo clinic were selected for inclusion.










